1. Home
  2. BFC vs DVAX Comparison

BFC vs DVAX Comparison

Compare BFC & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFC
  • DVAX
  • Stock Information
  • Founded
  • BFC 1894
  • DVAX 1996
  • Country
  • BFC United States
  • DVAX United States
  • Employees
  • BFC 366
  • DVAX N/A
  • Industry
  • BFC Major Banks
  • DVAX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BFC Finance
  • DVAX Health Care
  • Exchange
  • BFC Nasdaq
  • DVAX Nasdaq
  • Market Cap
  • BFC 1.3B
  • DVAX 1.2B
  • IPO Year
  • BFC N/A
  • DVAX 2004
  • Fundamental
  • Price
  • BFC $132.36
  • DVAX $10.15
  • Analyst Decision
  • BFC Buy
  • DVAX Buy
  • Analyst Count
  • BFC 2
  • DVAX 4
  • Target Price
  • BFC $137.00
  • DVAX $26.50
  • AVG Volume (30 Days)
  • BFC 88.5K
  • DVAX 1.3M
  • Earning Date
  • BFC 10-21-2025
  • DVAX 11-06-2025
  • Dividend Yield
  • BFC 1.36%
  • DVAX N/A
  • EPS Growth
  • BFC N/A
  • DVAX N/A
  • EPS
  • BFC 7.11
  • DVAX N/A
  • Revenue
  • BFC $168,744,000.00
  • DVAX $316,268,000.00
  • Revenue This Year
  • BFC $11.79
  • DVAX $23.23
  • Revenue Next Year
  • BFC $32.03
  • DVAX $16.57
  • P/E Ratio
  • BFC $18.62
  • DVAX N/A
  • Revenue Growth
  • BFC N/A
  • DVAX 26.66
  • 52 Week Low
  • BFC $90.01
  • DVAX $9.20
  • 52 Week High
  • BFC $135.72
  • DVAX $14.63
  • Technical
  • Relative Strength Index (RSI)
  • BFC 57.56
  • DVAX 53.08
  • Support Level
  • BFC $119.72
  • DVAX $9.71
  • Resistance Level
  • BFC $135.72
  • DVAX $10.12
  • Average True Range (ATR)
  • BFC 4.96
  • DVAX 0.23
  • MACD
  • BFC -0.14
  • DVAX 0.03
  • Stochastic Oscillator
  • BFC 79.00
  • DVAX 67.69

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: